Sanofi-Aventis Heart Drug Approved by FDA

Boston (DbTechNo) – The FDA (Food and Drug Administration) have just approved a drug made by Sanofi-Aventis for treating patients with heart arrhythmias.

Arrhythmias are characterized by tan abnormal heartbeat, which can result in death if not treated properly and timely.

The drug is called Multaq, and was approved by the FDA after a 3 year delay.

It will be sold in pill form in a dose of 400-milligrams and is taken twice daily.

According to Sanofi their drug is the first on the market to treat atrial fibrillation to show reduced numbers of hospitalizations due to irregular heartbeats.

The drug maker has also filed for approval for their drug in Europe and are awaiting a decision.

• Share
• Tweet
• "&title=""">